A&G Precision Antibody We have become recognized as a preeminent contract antibody development company. On average, we can complete a project four to five times faster than our competition, with a success rate exceeding 90%. Since our establishment in 2000, we have developed more than 1,000 novel, customized antibodies for pharmaceutical and biotechnology companies as well as federal and academic research laboratories. Our services are distinguished by: Consistently rapid turnaround on projects that yield successful custom development of high-affinity, high-content, application-specific antibodies Ability to deliver on challenging projects, such as antibodies that recognize a single amino acid mutation, cleavage site-specific antibodies, or antibodies with a Kd as low as 1 x 10-12 M No-risk guarantee whereby We assume the majority of the financial risk until successful antibodies are delivered to the client. We employ a staff of 20 based in an 8,000-square-foot laboratory facility in Columbia, Maryland.